The Cattle Creek Confluence Coalition — — is holding a public meeting on this topic on Thursday, Nov. 6, at 6:30pm in ...

It's a case of so far, so good for BlueRock Therapeutics' first clinical trial of Parkinson's disease therapy bemdaneprocel, with no major safety issues reported after a year in patients who received ...

Researchers have developed a synthetic regeneration system for genetically editing crops, avoiding the challenging step of ...

Oct. 5, 2025 — A new study shows glioblastoma isn’t confined to the brain—it erodes the skull and hijacks the immune system within skull marrow. The cancer opens channels that let inflammatory cells ...